Akebia Therapeutics Inc logo

Akebia Therapeutics Inc

NEW
STU:AX9 (USA)  
€ 1.065 +0.013 (+1.24%) Jul 2
At Loss
P/B:
12.11
Market Cap:
€ 292.10M ($ 334.41M)
Enterprise V:
€ 194.07M ($ 222.19M)
Volume:
1.04K
Avg Vol (2M):
56.37K
Trade In:
Volume:
1.04K
At Loss
Avg Vol (2M):
56.37K

Akebia Therapeutics Inc Valuation Measures